Akouos Inc (AKUS)

AKUS was delisted on the 30th of November, 2022.

• Market cap: $491M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.

Employees: 103